• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/20

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

20 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)
ProAir HFA/Ventolin HFA/Proventil HFA
Albuterol
Beta-2 Adrenergic Agonist
Bronchodilator
Asthma
Exercise-induced asthma; Prophylaxis
ADR:
Cardiovascular: Tachyarrhythmia
Endocrine metabolic: Hypokalemia
Gastrointestinal: Nausea (10% ), Pharyngitis (14% ), Throat irritation (10% )
Neurologic: Feeling nervous (7% ), Headache (7% ), Tremor (7% )
Respiratory: Cough (5% ), Rhinitis (5% to 16% ), Upper respiratory infection (21% ), Viral lower respiratory infection (7% )
Xopenex
levalbuterol
Beta-2 Adrenergic Agonist
Bronchodilator
Asthma
Cardiovascular: Chest pain, Palpitations, Tachyarrhythmia
Gastrointestinal: Vomiting (10.5% (pediatrics) )
Neurologic: Tremor
Psychiatric: Feeling nervous
Respiratory: Asthma (9.4% ), Pharyngitis (6.6% to 7.9% ), Rhinitis (7.4% )
Foradil
Formoterol
Beta-2 Adrenergic Agonist
Bronchodilator
Asthma
COPD
Exercise-induced asthma; Prophylaxis
Cardiovascular: Palpitations
Gastrointestinal: Diarrhea (4.9% ), Nausea (4.9% ), Xerostomia (1.3% to 3.3% )
Neurologic: Dizziness (0.9% to 2.4% ), Headache (2.5% ), Insomnia (2.4% ), Tremor (6.4% to 8.6% )
Psychiatric: Restlessness
Serevent
Salmeterol
Beta-2 Adrenergic Agonist
Bronchodilator
Asthma
COPD
Exercise-induced asthma; Prophylaxis
Nocturnal asthma
Cardiovascular: Tachyarrhythmia
Neurologic: Dizziness, Headache, Tremor
Respiratory: Throat irritation
Symbicort
Formoterol/budesonide
Antiasthma, Anti-Inflammatory/Bronchodilator Combination
Asthma
COPD
Gastrointestinal: Oral candidiasis (1.4% to 6% ), Stomach ache (1.1% to 6.5% ), Vomiting (1.4% to 3.2% )
Immunologic: Oral candidiasis (1.4% to 3.2% )
Musculoskeletal: Backache (1.6% to 3.2% )
Neurologic: Headache (6.5% to 11.3% )
Respiratory: Nasal congestion (2.5% to 3.2% ), Nasopharyngitis (7.3% to 10.5% ), Pain in throat (6.1% to 8.9% ), Sinusitis (3.5% to 5.8% ), Upper respiratory infection (3.5% to 10.5% )
Other: Influenza (2.4% to 3.2% )
Advair
Salmeterol/fluticasone
Antiasthma, Anti-Inflammatory/Bronchodilator Combination
Asthma
COPD
Endocrine metabolic: Cushing's syndrome
Gastrointestinal: Oral candidiasis (asthma, 1% to 4%; COPD, 10% )
Musculoskeletal: Musculoskeletal pain (asthma, 2% to 4%; COPD, 9% )
Neurologic: Dizziness (4% ), Headache (9% to 16% )
Respiratory: Bronchitis (asthma, 2% to 8% ), Cough (asthma, 3% to 6% ), Difficulty speaking, Hoarse, Pharyngitis (asthma, 10% to 13% ), Upper respiratory infection (asthma, 21% to 27%; COPD, greater than 5% ), Viral lower respiratory infection (asthma, 4%; COPD, 6% )
Flovent HFA/Flovent Diskus
Fluticasone
Adrenal Glucocorticoid
Anti-Inflammatory
Corticosteroid, Intermediate
Allergic rhinitis
Asthma
Atopic dermatitis
Disorder of skin, Corticosteroid-responsive dermatoses
Rhinitis, Non-allergic
Gastrointestinal: Pharyngeal candidiasis
Respiratory: Epistaxis, Pharyngitis
Asmanex
Mometasone
Adrenal Glucocorticoid
Anti-Inflammatory
Corticosteroid, Strong
Allergic rhinitis
Asthma
Inflammatory hyperkeratotic dermatosis
Nasal polyp
Seasonal allergic rhinitis; Prophylaxis
Dermatologic: Atrophic condition of skin, Topical, Pruritus, Topical
Gastrointestinal: Abdominal pain (2%-3%, oral inhalation), Indigestion (3%-5%, oral inhalation), Nausea (1%-3%, oral inhalation)
Musculoskeletal: Backache (3%-6%, oral inhalation), Musculoskeletal pain (4%-8%, oral inhalation), Myalgia unspecified (2%-3%, oral inhalation)
Neurologic: Headache (4%, intranasal; 17%-22%, oral inhalation)
Reproductive: Dysmenorrhea (4%-9%, oral inhalation)
Respiratory: Allergic rhinitis (11%-15%, oral inhalation), Candidiasis, oral (4%-6%, oral inhalation), Epistaxis, Intranasal (5%), Pharyngitis (8%-13%, oral inhalation), Upper respiratory infection (8%-15%, oral inhalation)
Other: Burning sensation, Topical, Fatigue (13%, oral inhalation), Viral disease, Intranasal (3%)
Azmacort
Triamcinolone
Adrenal Glucocorticoid
Anti-Inflammatory
Corticosteroid, Intermediate
Dental Agent
Endocrine-Metabolic Agent
Asthma
Disorder of respiratory system
Nephrotic syndrome, idiopathic or lupus erythematosus-induced
Allergic rhinitis, perennial or seasonal
Endocrine metabolic: Cushing's syndrome
Neurologic: Headache (5.5% to 21% )
Respiratory: Pharyngitis (5.1% to 25% )
Other: Influenza-like illness (2% to 8.9% )
Pulmicort
Budesonide
Adrenal Glucocorticoid
Anti-Inflammatory
Endocrine-Metabolic Agent
Asthma
Crohn's disease
Rhinitis, allergic and non-allergic
Ulcerative colitis, Distal
Gastrointestinal: Diarrhea (oral, 10% ), Nausea (inhalation, 1.8% to 6%; oral, 11% )
Musculoskeletal: Arthralgia (inhalation, 6%; oral, 5% )
Neurologic: Headache (inhalation, 3%; oral, 21% )
Respiratory: Epistaxis (intranasal, 8% ), Nasal stinging/burning (intranasal, greater than 1% ), Respiratory tract infection (inhalation, 3% to 32%; oral, 11% ), Sinusitis (inhalation, 3% to 16%; oral, 8% )
Beclovent/QVAR/Vanceril
Beclomethasone
Adrenal Glucocorticoid
Anti-Inflammatory
Asthma
Nasal polyp, recurrence following surgical removal; Prophylaxis
Rhinitis, allergic or non-allergic; seasonal or perennial
Neurologic: Headache
Respiratory: Candidiasis, Nasopharyngeal irritation
Alvesco
Ciclesonide
Adrenal Glucocorticoid
Anti-Inflammatory
Allergic rhinitis
Asthma
Musculoskeletal: Arthralgia (oral inhalation, 0.9% to 3.5% ), Backache (oral inhalation, 0.6% to 3.1% )
Neurologic: Headache (intranasal, greater than 1% ; oral inhalation, 4.9% to 11% )
Otic: Otalgia (intranasal, 2.2% )
Respiratory: Epistaxis (intranasal, 4.9% ), Nasal congestion (oral inhalation, 1.8% to 5.5% ), Nasopharyngitis (intranasal, 3.7% ; oral inhalation, 7% to 10.5% ), Pain in throat (oral inhalation, 2.4% to 4.7% ), Sinusitis (oral inhalation, 3.1% to 5.5% ), Upper respiratory infection (oral inhalation, 4.1% to 8.7% )
Other: Pain, In extremity (oral inhalation, 0.3% to 3.1% )
Aerobid
Flunisolide
Adrenal Glucocorticoid
Anti-Inflammatory
Asthma
Perennial allergic rhinitis
Cardiovascular: Palpitations
Gastrointestinal: Nausea and vomiting, Pharyngeal candidiasis
Neurologic: Headache
Respiratory: Difficulty speaking, Nasal irritation
Combivent 
Albuterol/Ipratropium
■Bronchodilator

COPD, For patients requiring a second bronchodilator

■Cardiovascular: Hypertension (less than 2% ), Tachycardia (less than 2% )
■Gastrointestinal: Nausea (2% )
■Neurologic: Headache (5.6% )
■Respiratory: Bronchitis (12.3% ), Cough (4.2% ), Disorder of respiratory system (2.5% ), Dyspnea (4.5% ), Pharyngitis (2.2% ), Sinusitis (2.3% ), Upper respiratory infection (10.9% )
Atrovent HFA 
Ipratropium
■Anticholinergic
■Bronchodilator
■Nasal Agent

COPD
nasal discharge

■Gastrointestinal: Abnormal taste in mouth, Bitter, Xerostomia
■Respiratory: Nasal congestion, Nasal mucosa dry
Spiriva 
Tiotropium 
■Antimuscarinic
■Bronchodilator

COPD

■Gastrointestinal: Constipation (4% ), Xerostomia (12% to 16% )
■Respiratory: Pharyngitis (7% to 9% ), Sinusitis (3% to 11% ), Upper respiratory infection (41% to 43% )
Singulair 
Montelukast
■Anti-Inflammatory
■Leukotriene Pathway Inhibitor

Asthma
Exercise-induced asthma; Prophylaxis
Perennial allergic rhinitis
Seasonal allergic rhinitis

Neurologic: Headache
Accolate 
Zafirlukast 
■Anti-Inflammatory
■Leukotriene Pathway Inhibitor

Asthma

Headache
SloBid, Theodur, Uniphyllin 
Theophylline 
■Bronchodilator
■Methylxanthine

Asthma
COPD

■Gastrointestinal: Nausea, Vomiting
■Neurologic: Headache, Insomnia, Tremor
■Psychiatric: Irritability, Restlessness
Xolair
Omalizumab 
■Antiasthma
■Monoclonal Antibody

IgE-mediated allergic asthma

■Dermatologic: Injection site reaction (45% any grade; 12% severe )
■Neurologic: Headache (subcutaneous 15% ; aerosol, 75% )
■Respiratory: Pharyngitis (11% ), Sinusitis (16% ), Upper respiratory infection (20% ), Viral disease (23% )